首页> 外文期刊>Journal of biopharmaceutical statistics >Median-based incremental cost-effectiveness ratios with censored data
【24h】

Median-based incremental cost-effectiveness ratios with censored data

机译:Median-based incremental cost-effectiveness ratios with censored data

获取原文
获取原文并翻译 | 示例
           

摘要

Cost-effectiveness is an essential part of treatment evaluation, in addition to effectiveness. In the cost-effectiveness analysis, a measure called the incremental cost-effectiveness ratio (ICER) is widely utilized, and the mean cost and the mean (quality-adjusted) life years have served as norms to summarize cost and effectiveness for a study population. Recently, the median-based ICER was proposed for complementary or sensitivity analysis purposes. In this article, we extend this method when some data are censored.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号